Agf Investments Inc. United Therapeutics Corp Transaction History

Agf Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$166.16 - $213.96 $310,719 - $400,105	-1,870 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$184.32 - $216.08 $197,222 - $231,205	1,070 Added 133.75%	1,870 $404,000
Q3 2021 Nov 10, 2021	SELL	$179.86 - $214.88 $30,576 - $36,529	-170 Reduced 17.53%	800 $148,000
Q2 2021 Aug 10, 2021	SELL	$170.47 - $211.93 $24,888 - $30,941	-146 Reduced 13.08%	970 $174,000
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $41,255 - $46,859	-268 Reduced 19.36%	1,116 $187,000
Q4 2020 Feb 08, 2021	SELL	$101.87 - $151.79 $211,685 - $315,419	-2,078 Reduced 60.02%	1,384 $210,000
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $83,416 - $101,143	835 Added 31.79%	3,462 $350,000
Q2 2020 Aug 11, 2020	SELL	$92.74 - $125.82 $11,499 - $15,601	-124 Reduced 4.51%	2,627 $318,000
Q1 2020 May 08, 2020	BUY	$79.39 - $115.35 $218,401 - $317,327	2,751 New	2,751 $261,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.